🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1992-10
Trial ID
NCT00002515
To determine survival outcomes for patients with chemosensitive brest cance...
Status
Completed
Location
Stanford University Cancer Center
Start Date
TBD
Trial ID
NCT00186641
Treatments Being Tested
This is a randomized, open-label, prospective, multicenter phase III superi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center,
Start Date
2026-08-11
Trial ID
NCT07678229
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Fox Chase - Temple Cancer Center
Start Date
1993-02
Trial ID
NCT00002521
This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-04
Trial ID
NCT07572123
Treatments Being Tested
This is a Phase II multi-center trial single arm trial of autologous transp...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2021-10-25
Trial ID
NCT04975698
Treatments Being Tested
This is a standard of care document, outlining the therapy for children wit...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2012-03-28
Trial ID
NCT01526603
The purpose of this study is to evaluate the effectiveness of Bortezomib wh...
Status
Completed
Location
H. Lee Moffitt Cancer Center
Start Date
2009-06-18
Trial ID
NCT00948922
Treatments Being Tested
Chronic Granulomatous Disease (CGD) is an inherited immunodeficiency disord...
Status
Completed
Location
University of California, Los Angeles (UCLA)
Start Date
2015-10-29
Trial ID
NCT02234934
Treatments Being Tested
Plerixafor, administered at a dose of 240 ug/kg, potentiates the effect of ...
Status
Completed
Location
Duke University Medical Center
Start Date
2009-05
Trial ID
NCT00901225
Treatments Being Tested